Lab News
Illumina unveils megadeal with Roche, new sequencers
January 14, 2020 -- SAN FRANCISCO - Illumina showcased a new 15-year next-generation sequencing collaboration with Roche and two new sequencing systems during its company presentation on January 13 at the annual J.P. Morgan Healthcare Conference.
Discuss
January 14, 2020 -- SAN FRANCISCO - Illumina showcased a new 15-year next-generation sequencing collaboration with Roche and two new sequencing systems during its company presentation on January 13 at the annual J.P. Morgan Healthcare Conference.
Discuss AACC guides on biotin interference: Communication is key
January 13, 2020 -- The American Association for Clinical Chemistry (AACC) has released a new guidance document for tackling the risk of interference from biotin (vitamin B7) in lab test results that stresses interdisciplinary communication.
Discuss
January 13, 2020 -- The American Association for Clinical Chemistry (AACC) has released a new guidance document for tackling the risk of interference from biotin (vitamin B7) in lab test results that stresses interdisciplinary communication.
Discuss Oncotype DX gene test shows promise for guiding radiation therapy
January 13, 2020 -- Scores for breast cancer patients on the Oncotype DX 21-gene risk test were significantly associated with local disease recurrence in a retrospective study published online January 6 in JAMA Oncology. The data suggest an expanded role for the test, though long-term, prospective validation data are needed to move it into practice.
Discuss
January 13, 2020 -- Scores for breast cancer patients on the Oncotype DX 21-gene risk test were significantly associated with local disease recurrence in a retrospective study published online January 6 in JAMA Oncology. The data suggest an expanded role for the test, though long-term, prospective validation data are needed to move it into practice.
Discuss AI seeks role in evaluating prostate biopsies
January 9, 2020 -- An investigational artificial intelligence (AI) system demonstrated excellent performance for differentiating benign from cancerous findings in prostate biopsies and matched the performance of urological pathologist experts for gauging disease severity, researchers reported online January 8 in Lancet Oncology.
Discuss
January 9, 2020 -- An investigational artificial intelligence (AI) system demonstrated excellent performance for differentiating benign from cancerous findings in prostate biopsies and matched the performance of urological pathologist experts for gauging disease severity, researchers reported online January 8 in Lancet Oncology.
Discuss Genetics group guides labs on fetal exome sequencing
January 8, 2020 -- Clinical laboratories are advised to have clearly defined turnaround times for fetal exome sequencing and reporting policies for incidental findings and variants of uncertain significance, among other things, in new guidance published January 8 by the American College of Medical Genetics and Genomics.
Discuss
January 8, 2020 -- Clinical laboratories are advised to have clearly defined turnaround times for fetal exome sequencing and reporting policies for incidental findings and variants of uncertain significance, among other things, in new guidance published January 8 by the American College of Medical Genetics and Genomics.
Discuss U.S. cancer death rate drops again
January 8, 2020 -- Fewer Americans are dying of cancer, and the mortality rate appears to be dropping faster than ever, according to new data released January 9 by the American Cancer Society. Cancer mortality in the U.S. has fallen 29% in the last 26 years, including a sharp 2.2% drop from 2016 to 2017.
Discuss
January 8, 2020 -- Fewer Americans are dying of cancer, and the mortality rate appears to be dropping faster than ever, according to new data released January 9 by the American Cancer Society. Cancer mortality in the U.S. has fallen 29% in the last 26 years, including a sharp 2.2% drop from 2016 to 2017.
Discuss Machine learning, tumor DNA testing a winning combo in colon cancer
January 7, 2020 -- A new machine-learning platform helped identify patients with colorectal cancer and predict disease severity with high accuracy in a study of circulating tumor DNA samples, Chinese researchers reported in Science Translational Medicine.
Discuss
January 7, 2020 -- A new machine-learning platform helped identify patients with colorectal cancer and predict disease severity with high accuracy in a study of circulating tumor DNA samples, Chinese researchers reported in Science Translational Medicine.
Discuss Whole exome sequencing not always what it's cracked up to be
January 6, 2020 -- Depending on the reporting lab, whole exome sequencing test results may be incomplete and falsely reassuring if negative, according to a small study published in Clinical Chemistry on January 6. Targeted panel tests may be a better bet for some patients, and labs need to be continually working to improve performance, researchers concluded.
Discuss
January 6, 2020 -- Depending on the reporting lab, whole exome sequencing test results may be incomplete and falsely reassuring if negative, according to a small study published in Clinical Chemistry on January 6. Targeted panel tests may be a better bet for some patients, and labs need to be continually working to improve performance, researchers concluded.
Discuss Testing for inherited cholesterol condition falls far short
January 3, 2020 -- Though much is known about the nature and risks of familial hypercholesterolemia, testing and diagnosis rates still fall far short, according to a global report calling for action that was published online January 2 in JAMA Cardiology.
Discuss
January 3, 2020 -- Though much is known about the nature and risks of familial hypercholesterolemia, testing and diagnosis rates still fall far short, according to a global report calling for action that was published online January 2 in JAMA Cardiology.
Discuss Lynparza PARP approval opens door to more pancreatic cancer testing
January 2, 2020 -- Approval of the drug olaparib (Lynparza, Merck/AstraZeneca) by the U.S. Food and Drug Administration at the end of 2019 paves the way for more testing and targeted treatment of patients with pancreatic cancer.
Discuss
January 2, 2020 -- Approval of the drug olaparib (Lynparza, Merck/AstraZeneca) by the U.S. Food and Drug Administration at the end of 2019 paves the way for more testing and targeted treatment of patients with pancreatic cancer.
Discuss
News in Brief
Conferences
Society for Laboratory Automation and Screening (SLAS) 2020
January 25-29
San Diego, California United States
January 25-29
San Diego, California United States
American Society for Microbiology (ASM) Biothreats
January 28-30
Arlington, Virginia United States
January 28-30
Arlington, Virginia United States
Festival of Genomics 2020
January 29-30
London, Greater London United Kingdom
January 29-30
London, Greater London United Kingdom
Medlab Middle East
February 3-6
Dubai, Dubai United Arab Emirates
February 3-6
Dubai, Dubai United Arab Emirates
Park City Anatomic Pathology Update
February 9-13
Park City, Utah United States
February 9-13
Park City, Utah United States
Connect
Latest Tweets